ArticleCemiplimab for Unresectable Cutaneous Squamous Cell Carcinoma: Experience From a Tertiary CenterAuthor:Arka Banerjee, MA (Cantab), MB, BChir Publish date: June 30, 2026Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer and ranks sixth in prevalence among all cancers in the United Kin... Read More